Related Experiment Video
Updated: Feb 1, 2026

Intramyocardial Transplantation of MSC-Loading Injectable Hydrogels after Myocardial Infarction in a Murine Model
Published on: September 20, 2020
A Case Report of Penicillin-Tolerant Streptococcus mitis Endocarditis Chang-Hua Chen, MD, MSc, PhD
1Department of Internal Medicine, Changhua Christian Hospital, Taiwan.
Abstract:
There is no clear relationship between the serum inhibition test and clinical outcome for Streptococcus mitis (S. mitis) endocarditis. We report an 84-year-old male with endocarditis caused by penicillin-tolerant S. mitis. The results for the serum inhibitory test (SIT) and serum bactericidal test (SBT) showed a trough level of SIT = 1:256 and SBT = 1:4 and a peak level of SIT ≥ 1:1024 and SBT = 1:16. In addition, the SIT/SBT ratio was 64 at peak level and more than 64 at trough level, which is compatible with penicillin-tolerant S. mitis. Following a 42-day high-dose penicillin treatment (24 M IU/day, via a continuous drip), the patient made a good recovery. In vitro inhibitory and bactericidal test results were not a valid predictor of medical treatment failure. Physicians need to continue to evaluate the surgical indications when treating patients with S. mitis endocarditis.
Insights
Serum inhibition tests do not reliably predict treatment success for Streptococcus mitis endocarditis. Penicillin-tolerant S. mitis endocarditis can resolve with high-dose penicillin, despite in vitro test results.
Area of Science:
- Infectious Diseases
- Cardiology
- Microbiology
Background:
- Streptococcus mitis endocarditis (S. mitis) is a serious infection.
- Predicting treatment outcomes for S. mitis endocarditis can be challenging.
- The role of in vitro tests like serum inhibition tests (SIT) and serum bactericidal tests (SBT) in guiding therapy is unclear.
Observation:
- An 84-year-old male presented with endocarditis caused by penicillin-tolerant S. mitis.
- In vitro testing revealed high serum inhibitory and bactericidal levels, with a high SIT/SBT ratio, consistent with penicillin tolerance.
- The patient received a 42-day course of high-dose intravenous penicillin.
Findings:
- The patient achieved a good clinical recovery following treatment.
- In vitro SIT and SBT results did not accurately predict the successful medical treatment outcome.
- The SIT/SBT ratio indicated penicillin tolerance, yet high-dose penicillin therapy was effective.
Implications:
- In vitro tests may not be reliable predictors of treatment failure in penicillin-tolerant S. mitis endocarditis.
- Physicians must carefully consider surgical intervention indications, even with seemingly unfavorable in vitro test results.
- Clinical judgment remains paramount in managing S. mitis endocarditis, particularly in cases of penicillin tolerance.
Related Concept Videos
Net Change Theorem
Endocarditis IV: Nursing Management
Endocarditis III: Medical Management
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Global Climate Change

